Megan Settle

1.4k citations
9 papers · 1.3k · 1 hit paper · h-index 9

Impact in

    • Paraoxonase enzyme and polymorphisms
  • Immunology top 5%
    • Atherosclerosis and Cardiovascular Diseases
    • Neutrophil, Myeloperoxidase and Oxidative Mechanisms

Papers in

    • Atherosclerosis and Cardiovascular Diseases 4
    • Neutrophil, Myeloperoxidase and Oxidative Mechanisms 2
    • Phagocytosis and Immune Regulation 1
    • Cholesterol and Lipid Metabolism 6

Megan Settle

9 papers receiving 1.2k citations

Megan Settle's Hit Papers

Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease 2004 · 647 citations
6470+7+14Years since publication200400600

Peers

Megan Settle
Comparison fields: 5 of 66
  • Clinical Biochemistry 121
  • Immunology 373
  • Surgery 596
  • Biochemistry 82
  • Physiology 132
Replace Masakazu Sakai with:
Masakazu Sakai Japan
Constanze Bergt United States
U P Steinbrecher Canada
Junichiro Tohyama United States
Fanny Robbesyn France
Martha M. Hokom United States
Lori J. Royer United States
Lawrence Chan United States
Ellen Knutsen Rydberg Sweden
Eric T. Alexander United States
Megan Settle relative to Masakazu Sakai Japan Masakazu Sakai's profile →
Citations per field
00.5×1.5×1.9×
Masakazu Sakai · 1×
Citations per year

Countries citing papers authored by Megan Settle

Since Specialization
Citations

This map shows the geographic impact of Megan Settle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Megan Settle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Megan Settle more than expected).

Fields of papers citing papers by Megan Settle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Megan Settle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Megan Settle. The network helps show where Megan Settle may publish in the future.

Co-authors

The 25 scholars most cited alongside Megan Settle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Megan Settle Line = papers co-authored together Megan Settle links everyone, so they are left out of the graph.

All Works

9 of 9 papers shown
#Work
1
Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease
Hit paper breakdown →
2004647
2 2004181
3 2004113
4 201479
5 200474
6 200568
7 200544
8 200542
9 200616

About Megan Settle

Megan Settle is a scholar working on Immunology, Surgery, Oncology, Nuclear Energy and Engineering and Waste Management and Disposal, having authored 9 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cholesterol and Lipid Metabolism (6 papers), Atherosclerosis and Cardiovascular Diseases (4 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (2 papers), Drug Transport and Resistance Mechanisms (1 paper) and Phagocytosis and Immune Regulation (1 paper). The work is most often cited by research in Clinical Biochemistry (121 citations), Immunology (373 citations), Surgery (596 citations), Biochemistry (82 citations) and Physiology (132 citations). Megan Settle has collaborated with scholars based in United States, Uruguay and France. Frequent co-authors include Jonathan D. Smith, Lemin Zheng, Michael T Kinter, Stanley L. Hazen, Gregory Brubaker, Marie‐Luise Brennan, Leonor Thomson, Harry Ischiropoulos, Mingjiang Sun and Paul L. Fox. Their work appears in journals such as Arteriosclerosis Thrombosis and Vascular Biology, Journal of Lipid Research, Journal of Biological Chemistry, Journal of Clinical Investigation and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact